InsidersTradesSigma
Cinclus Pharma Holding AB (publ): directors' dealings · Finland · FIN-FSA
FI:cinclus-pharma-holding-ab-publSE0020388577FI·FIN-FSAMcap 555M€Healthcare
Explore the full insider trade history of Cinclus Pharma Holding AB (publ), a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Cinclus Pharma Holding AB (publ) has recorded 1 reports. Market capitalisation: €554.7m. The latest transaction was disclosed on 23 March 2026 (Purchase). Among the most active insiders: Jesper Wiklund. The full history is free.
1
Insider Decl.
0
Thresholds
€10,009
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
11.92 €
Analyst consensus
4 analystsStrong buy
25.00 €Target 46.25 €(+288%)70.00 €
Income statement
Revenue57.5 M€
Net income−184.0 M€-320.1% margin
Valuation
PER (forward)-2.1x
P/Book1.5x
Balance sheet & cash
Market cap554.7 M€
Total debt7.9 M€
Free Cash Flow−75.8 M€
Debt / Equity2%
Profitability & ownership
ROE-39.8%
ROA-21.6%
% insiders37.6%
% institutions34.3%
Last declaration on 23 March 2026
Declarations1 total
Executives●Purchase21FIN-FSA
€10,0096,000 shares@ €1.66820.0018% mcap100.0% of flow
Aktie
FI:A003X228-1·
Ideal exit: 15 Dec 2026 (T+270)
1 of 1 declaration